Nanosonics Ltd (ASX: NAN) Share Price and News

Dr Marshall is a technology innovator, physicist and business leader. Until July 2023, Dr Marshall was Chief Executive of CSIRO for eight and a half years. During his 26 years in the US, Dr Marshall co-founded six companies in a range of markets including medical device which went public. Over the past 30 years, he has served as CEO/ MD of six companies, and Chairman of four. He was MD, then co-Chairman of Arasor which he took public in 2006. In 2007, Dr Marshall became MD of Southern Cross Venture Partners, a Silicon Valley VC firm specializing in Australian innovation. He has been a director of 20 private sector boards in Australia and the US, including boards of two companies that were subsequently publicly listed. He is a member of the Innovation & Development and the People & Culture, Safety Committee.

Mr Kavanagh has 30 years of international commercial experience in the healthcare sector, Michael has a record of driving innovation, operational excellence, and sustainable growth across the medical device and pharmaceutical industries. Prior to joining Nanosonics, Michael served on the Executive Team of Cochlear Ltd for more than a decade as Senior Vice President of Global Marketing. He is a member of the Innovation & Development Committee.

Ms McDonald brings with her a background in corporate and commercial law, having practiced for many years as a partner at Ashurst. Ms McDonald was Chair of the Corporations Committee of the Business Law Section of the Law Council of Australia (2012 to 2013) and was a member of the Australian Takeovers Panel from 2001 to 2010. She is a member of the Risk committee and the Chair of the People & Culture, Safety Committee.

Mr Sargent career included 22 years at General Electric, where he received multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the US, Europe and Asia Pacific. Mr Sargent has been a Non-Executive Director of Origin Energy Limited and is also a Non-Executive Director of Ramsay Healthcare Limited (since December 2021). Mr Sargent's unlisted board activities include Non-Executive Director of The Great Barrier Reef Foundation and Chairman of Origin Energy's philanthropic arm, The Origin Foundation. Mr Sargent was previously Chair of OFX Group Limited (2016 to 2022), and Nonexecutive Director of Veda Group Limited. He is a member of the Risk, Innovation & Development and the People & Culture, Safety Committee.

Dr Batten has over 30 years of experience in the healthcare sector in non-executive and executive roles, and medical practitioner and clinical roles. Dr Batten was CEO of Imperial College Healthcare NHS Trust in the UK, St Vincent's Health Australia, Eastern Health and Dental Health Services Victoria. She is a member of the Risk and Innovation & Development Committee.

Mr Dalbosco had an executive career, most notably at EY, where he held senior leadership roles spanning multiple regions and functions, including Oceania Managing Partner and CEO, Asia Pacific Joint Deputy CEO, and Oceania Managing Partner - Transaction Advisory Services. Mr Dalbosco retired from the EY partnership in 2020. Mr Dalbosco's previous governance roles include Mercy Health & Aged Care, Berry Street Victoria and the Committee for Melbourne. Mr Dalbosco is currently a Non-Executive Director at Medibank Private Ltd and serves as Chair of Melbourne Archdiocese Catholic Schools. He is also Chair of the Gillespie Family Council & Gillespie Family Foundation (founders/owners of Bakers Delight). He is Chair of the Risk Committee and a member of the People & Culture, Safety Committee.

-

-

-

-

-

-

-

-

-

-

-

-